- Home
- SLI vs LAB Comparison
SLI vs LAB Comparison
Compare SLI & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLI
- LAB
- Stock Information
- Founded
- SLI 1998
- LAB 1999
- Country
- SLI Canada
- LAB United States
- Employees
- SLI N/A
- LAB N/A
- Industry
- SLI Major Chemicals
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- SLI Industrials
- LAB Industrials
- Exchange
- SLI Nasdaq
- LAB Nasdaq
- Market Cap
- SLI 595.8M
- LAB 504.2M
- IPO Year
- SLI N/A
- LAB 2011
- Fundamental
- Price
- SLI $3.78
- LAB $1.20
- Analyst Decision
- SLI Strong Buy
- LAB Buy
- Analyst Count
- SLI 3
- LAB 2
- Target Price
- SLI $5.42
- LAB $2.50
- AVG Volume (30 Days)
- SLI 8.0M
- LAB 1.6M
- Earning Date
- SLI 11-10-2025
- LAB 11-04-2025
- Dividend Yield
- SLI N/A
- LAB N/A
- EPS Growth
- SLI N/A
- LAB N/A
- EPS
- SLI N/A
- LAB N/A
- Revenue
- SLI N/A
- LAB $172,271,000.00
- Revenue This Year
- SLI N/A
- LAB N/A
- Revenue Next Year
- SLI N/A
- LAB N/A
- P/E Ratio
- SLI N/A
- LAB N/A
- Revenue Growth
- SLI N/A
- LAB 76.33
- 52 Week Low
- SLI $1.08
- LAB $0.92
- 52 Week High
- SLI $6.40
- LAB $2.32
- Technical
- Relative Strength Index (RSI)
- SLI 44.62
- LAB 42.25
- Support Level
- SLI $3.68
- LAB $1.12
- Resistance Level
- SLI $3.99
- LAB $1.44
- Average True Range (ATR)
- SLI 0.42
- LAB 0.09
- MACD
- SLI -0.14
- LAB -0.02
- Stochastic Oscillator
- SLI 9.34
- LAB 22.86
About SLI Standard Lithium Ltd.
Standard Lithium Corp is engaged in the exploration and development of lithium brine properties in the United States. The company is focused on the exploration and development of the Arkansas Lithium Project, which is located in south-central Arkansas. Its other projects comprise the Lanxess Project, and Bristol Dry Lake Project.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.